对最初发现的胰腺囊性病变患者进行基于影像学的监测
本回顾性观察研究纳入2015年1月至2016年12月经MRI偶然发现0.5-4.0 cm胰腺囊性病变的911例患者,评估影像监测方案与恶性进展检出的关联。随访中位45.0个月,20例恶性进展均发生于导管内乳头状黏液性肿瘤(IPMN)患者;累积MRI检查次数与1年及2年界点恶性进展检出显著相关(HR=1.40,P=0.035;HR=1.38,P=0.047),CT无此关联。结论认为影像监测应优先关注IPMN,基于MRI的监测在最初2年可能有益,尤其对无警示特征的IPMN患者。
要点
- 偶然发现的胰腺囊性病变随访中,恶性进展仅见于IPMN患者。
- 累积MRI检查次数与1年及2年界点恶性进展检出相关,CT无此关联。
- 无警示特征的IPMN患者中MRI累积检查次数与恶性进展相关,有警示特征者未显示关联。
核心结论
- 对偶然发现的胰腺囊性病变进行影像监测以检出恶性进展时,应优先关注IPMN。
- 基于MRI的监测在最初2年可能有益,尤其对无警示特征的IPMN患者。
研究设计与样本
- 回顾性观察研究,纳入2015年1月至2016年12月经MRI偶然发现0.5-4.0 cm胰腺囊性病变的患者911例(平均年龄68.8岁;445例为IPMN)。
- 记录影像检查方式、时间间隔、累积影像检查次数及恶性进展发生情况,随访中位45.0个月,最长9年。
- 采用Cox回归分析评估累积CT/MRI检查次数对1年、2年及3年界点恶性进展检出的影响。
诊断标准与关键数值
- 全部20例恶性进展均发生于IPMN患者,在最长9年随访中持续增加。
- 累积MRI检查次数与1年界点恶性进展检出显著相关(HR=1.40;P=0.035),与2年界点亦显著相关(HR=1.38;P=0.047);CT未见此类关联。
- 在350例无警示特征的IPMN患者中,累积MRI检查次数与1年界点(HR=1.63;P=0.007)及2年界点(HR=1.59;P=0.013)恶性进展相关;在95例有警示特征的IPMN患者中未见此关联。
临床应用与阅片要点
- 对偶然发现的胰腺囊性病变进行监测时,应优先关注IPMN患者。
- 基于MRI的监测在最初2年可能有益,尤其对无警示特征的IPMN患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the long-term outcomes of pancreatic cystic lesions (PCLs) undergoing surveillance, and evaluate the associations between imaging monitoring plans and detection of malignant progression.
METHODS: This retrospective observational study included patients with incidentally detected PCLs (0.5-4.0 cm) on MRI between January 2015 and December 2016. Imaging modalities, time intervals, cumulative number of imaging examinations, and occurrence of malignant progression were recorded. The impact of cumulative CT/MRI examinations on detection of malignant progression at 1, 2, and 3-years was assessed using Cox-regression analyses.
RESULTS: A total of 911 patients (mean age, 68.8-years; 445 with intraductal papillary mucinous neoplasm [IPMN]) underwent an average of five examinations during follow-up (median, 45.0-months). All 20 cases of malignant progression occurred in patients with IPMN, increasing steadily over the maximum 9-year follow-up. The cumulative number of MRI examinations was significantly associated with detection of malignant progression at 1-year (hazard ratio [HR] = 1.40; P = 0.035), and 2-year (HR = 1.38; P = 0.047) landmark points, while CT showed no such association. The cumulative number of MRI examinations was associated with malignant progression at both 1-year (HR = 1.63; P = 0.007) and 2-year (HR = 1.59; P = 0.013) landmark points in 350 patients with IPMN without worrisome features, but not in 95 patients with IPMN with worrisome features.
CONCLUSION: Imaging surveillance of incidentally detected PCLs for detecting malignant progression should prioritize IPMNs. MRI-based surveillance would be beneficial in the initial 2-years, especially for patients with IPMN lacking worrisome features.
引用
- Park HJ, Kim S, Choi SH, et al. Imaging-based surveillance in patients with initially detected pancreatic cystic lesions. Eur J Radiol. 2025. PMID: 40215706. doi:10.1016/j.ejrad.2025.112102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。